Ryvu Therapeutics S.A.
WSE:RVU.WA
64.5 (PLN) • At close December 14, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) PLN.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 77.968 | 46.86 | 38.804 | 11.186 | 15.414 | 42.567 | 77.206 | 87.82 | 48.133 | 41.029 | 28.865 | 13.153 | 9.42 | 9.018 | 8.847 |
| Kosten van de omzet
| 19.58 | 17.554 | 17.406 | 13.725 | 8.765 | 92.721 | 29.651 | 25.926 | 16.865 | 14.837 | 9.702 | 6.005 | 5.729 | 2.915 | 2.926 |
| Brutowinst
| 58.388 | 29.306 | 21.398 | -2.539 | 6.65 | -50.154 | 47.555 | 61.894 | 31.268 | 26.192 | 19.163 | 7.148 | 3.691 | 6.103 | 5.92 |
| Brutowinstmarge
| 0.749 | 0.625 | 0.551 | -0.227 | 0.431 | -1.178 | 0.616 | 0.705 | 0.65 | 0.638 | 0.664 | 0.543 | 0.392 | 0.677 | 0.669 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 25.992 | 15.018 | 13.016 | 67.625 | 53.864 | 27.088 | 17.307 | 12.997 | 13.443 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 0 | 0 | 5.557 | 4.33 | 5.469 | 22.455 | 32.352 | 17.939 | 10.538 | 8.761 | 6.157 | 4.21 | 3.658 | 0 | 0 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 4.372 | 4.164 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 0 | 5.67 | 5.557 | 4.33 | 5.469 | 4.372 | 32.352 | 17.939 | 10.538 | 8.761 | 6.157 | 4.21 | 3.658 | 0 | 0 |
| Overige kosten
| 180.487 | 124.584 | 61.523 | 56.63 | 24.072 | -9.36 | 28.794 | 31.279 | 27.915 | 15.294 | 7.734 | 5.066 | 6.297 | 12.645 | 8.885 |
| Bedrijfskosten
| 180.487 | 130.254 | 93.072 | 75.978 | 42.556 | -4.988 | 61.146 | 49.218 | 38.453 | 24.055 | 13.891 | 9.276 | 9.955 | 12.645 | 8.885 |
| Bedrijfsresultaat
| -122.099 | -100.948 | -71.674 | -77.867 | -35.906 | -45.139 | -13.611 | 12.639 | -1.214 | 2.073 | 5.272 | -2.128 | -6.264 | -6.542 | -2.965 |
| Bedrijfsresultaat ratio
| -1.566 | -2.154 | -1.847 | -6.961 | -2.329 | -1.06 | -0.176 | 0.144 | -0.025 | 0.051 | 0.183 | -0.162 | -0.665 | -0.725 | -0.335 |
| Totaal overige inkomsten en kosten netto
| 10.961 | 8.836 | -0.773 | -0.363 | 5.081 | 1.276 | 1.362 | -3.038 | -0.069 | 0.748 | 0.155 | -0.198 | -0.164 | 2.104 | -0.433 |
| Inkomen voor belasting
| -111.138 | -92.112 | -79.195 | -77.419 | -30.616 | -36.029 | 8.986 | 9.6 | -1.283 | 2.821 | 5.427 | -2.367 | -6.428 | -4.611 | -3.398 |
| Inkomen voor belasting ratio
| -1.425 | -1.966 | -2.041 | -6.921 | -1.986 | -0.846 | 0.116 | 0.109 | -0.027 | 0.069 | 0.188 | -0.18 | -0.682 | -0.511 | -0.384 |
| Belastingkosten
| 0.297 | 0 | 4.587 | 0.116 | 1.072 | -0.03 | 8.093 | 2.868 | -3.968 | -3.412 | -0.423 | 0.019 | -0.112 | -0.172 | -1.425 |
| Nettowinst
| -111.435 | -92.112 | -83.782 | -77.535 | -31.688 | -35.999 | -0.106 | 6.407 | 2.72 | 6.27 | 5.85 | -2.385 | -6.428 | -4.439 | -1.974 |
| Nettowinstmarge
| -1.429 | -1.966 | -2.159 | -6.931 | -2.056 | -0.846 | -0.001 | 0.073 | 0.057 | 0.153 | 0.203 | -0.181 | -0.682 | -0.492 | -0.223 |
| WPA (Winst Per Aandeel)
| -4.82 | -4.02 | -4.57 | -4.22 | -1.89 | -2.25 | -0.007 | 0.48 | 0.2 | 0.48 | 0.56 | -0.23 | -0.61 | -0.42 | -0.19 |
| Verwaterde WPA
| -4.82 | -4.02 | -4.57 | -4.22 | -1.89 | -2.25 | -0.007 | 0.48 | 0.2 | 0.47 | 0.56 | -0.23 | -0.61 | -0.42 | -0.19 |
| EBITDA
| -96.834 | -81.044 | -65.206 | -65.959 | -17.871 | -35.722 | -17.257 | 17.885 | 2.479 | 5.558 | 7.609 | -0.212 | 159.289 | -3.03 | -1.679 |
| EBITDA ratio
| -1.242 | -1.729 | -1.68 | -5.896 | -1.159 | -0.839 | -0.224 | 0.204 | 0.051 | 0.135 | 0.264 | -0.016 | 16.91 | -0.336 | -0.19 |